Choleretics and Biliary Excretion of Antibiotics in RatsCoppi G. · Monti L. · Genova R.
Department of Microbiology, Research Laboratories of the ‘Istituto De Angeli’, Milan
Authors’ address: Dr. G. Coppi, Dr. L. Monti, and Dr. R. Genova, Department, of Microbiology, Research Laboratories of ‘Istituto de Angeli’, Via Serio 15, 20139 Milan (Italy). – Request reprints from Dr. G. Coppi
Do you have an account?
αα-Diethyl-1-naphthylacetic acid (DA 808) and α-methyl-α-(2-morpholinoethyl)-1-naphthylacetic acid (DA1627) are compared with dehydrocholic acid for activity on biliary excretion of penicillin G, ampicillin, methicillin, rifamycin SV, tetracycline and demethylchlortetracycline in rats. Unlike to dehydrocholic acid, DA 808 and DA 1627 do not decrease the concentrations of penicillins and tetracycline in the bile. The concentrations of rifamycin SV and demethylchlortetracycline are partially reduced by the two naphthylacetic acid derivatives and markedly reduced by dehydrocholic acid. DA 808 and DA 1627 increase, however, the total amount of the penicillins and tetracycline excreted in the bile but not that of demethylchlortetracycline and rifamycin SV. Dehydrocholic acid does not increase the amount of the antibiotics excreted in the bile. On the basis of these results some remarks of clinical therapy about the association of choleretics-antibiotics in the biliary infections are made.
© 1971 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.